{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:03:56Z","timestamp":1784358236917,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1007\/bf03034001","type":"journal-article","created":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T10:10:17Z","timestamp":1236766217000},"page":"65-72","source":"Crossref","is-referenced-by-count":27,"title":["The detection rates and tumor clinical\/pathological stages of whole-body FDG-PET cancer screening"],"prefix":"10.1007","volume":"21","author":[{"given":"Ken","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiji","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Omagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03034001_CR1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/BF01249629","volume":"23","author":"P Rigo","year":"1996","unstructured":"Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.Eur J Nucl Med 1996; 23: 1641\u20131674.","journal-title":"Eur J Nucl Med"},{"key":"BF03034001_CR2","first-page":"1508","volume":"32","author":"LP Adler","year":"1991","unstructured":"Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, et al. Noninvasive grading of musculoskeletal tumors using PET.J Nucl Med 1991; 32: 1508\u20131512.","journal-title":"J Nucl Med"},{"key":"BF03034001_CR3","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/0959-8049(95)00421-1","volume":"31A","author":"P Price","year":"1995","unstructured":"Price P, Jones T. Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy?Eur J Cancer 1995; 31A: 1924\u20131927.","journal-title":"Eur J Cancer"},{"key":"BF03034001_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF03164996","volume":"8","author":"J Okada","year":"1994","unstructured":"Okada J, Oonishi H, Yoshikawa K, Itami J, Uno K, Imaseki K, et al. FDG-PET for predicting the prognosis of malignant lymphoma.Ann Nucl Med 1994; 8: 187\u2013191.","journal-title":"Ann Nucl Med"},{"key":"BF03034001_CR5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<695::AID-CNCR6>3.0.CO;2-D","volume":"79","author":"B Nakata","year":"1997","unstructured":"Nakata B, Chung YS, Nishimura S, Nishihara T, Sakurai Y, Sawada T, et al.18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.Cancer 1997; 79: 695\u2013699.","journal-title":"Cancer"},{"key":"BF03034001_CR6","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W","volume":"82","author":"M Oshida","year":"1998","unstructured":"Oshida M, Uno K, Suzuki M, Nagashima T, Hashimoto H, Yagata H, et al. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro18F-D-glucose.Cancer 1998; 82: 2227\u20132234.","journal-title":"Cancer"},{"issue":"2","key":"BF03034001_CR7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1109\/23.106697","volume":"37","author":"TM Guerrero","year":"1990","unstructured":"Guerrero TM, Hoffman FJ, Dahlbom M, Cutler PD, Hawkins RA, Phelps ME. Characterization of a whole body imaging technique for PET.IEEE Trans Nucl Sci 1990; 37 (2): 676\u2013680.","journal-title":"IEEE Trans Nucl Sci"},{"key":"BF03034001_CR8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0969-8051(96)00074-1","volume":"23","author":"PS Conti","year":"1996","unstructured":"Conti PS, Lilien DJ, Hawley K, Keppler J, Grafton ST, Bading JR. PET and 18-[F] FDG in oncology: a clinical update.Nucl Med Biol 1996; 23: 717\u2013735.","journal-title":"Nucl Med Biol"},{"key":"BF03034001_CR9","first-page":"591","volume":"40","author":"D Delbeke","year":"1999","unstructured":"Delbeke D. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer lymphoma and melanoma.J Nucl Med 1999; 40: 591\u2013603.","journal-title":"J Nucl Med"},{"key":"BF03034001_CR10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0959-8049(99)00077-5","volume":"35","author":"U Lassen","year":"1999","unstructured":"Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L.18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).Eur J Cancer 1999; 35: 1076\u20131082.","journal-title":"Eur J Cancer"},{"key":"BF03034001_CR11","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(97)24051-1","volume":"350","author":"S Yasuda","year":"1997","unstructured":"Yasuda S, Shohtsu A. Cancer screening with whole-body18F-fluorodeoxyglucose positron-emission tomography.The Lancet 1997; 350: 1819.","journal-title":"The Lancet"},{"key":"BF03034001_CR12","first-page":"4103","volume":"24","author":"YK Chen","year":"2004","unstructured":"Chen YK, Ding HJY, Su CT, Shen YY, Chen LK, Liao AC, et al. Application of PET and PET\/CT imaging for Cancer Screening.Anticancer Res 2004; 24: 4103\u20134108.","journal-title":"Anticancer Res"},{"issue":"3","key":"BF03034001_CR13","first-page":"217","volume":"50","author":"YY Shen","year":"2003","unstructured":"Shen YY, Su CT, Chen GJS, Chen YK, Liao ACF, Tsai FS. The value of18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening.Neoplasma 2003; 50 (3): 217\u2013221.","journal-title":"Neoplasma"},{"key":"BF03034001_CR14","first-page":"835","volume":"49","author":"M Ide","year":"2004","unstructured":"Ide M. Cancer screening with FDG-PET.Jpn J Clin Radiol 2004; 49: 835\u2013840.","journal-title":"Jpn J Clin Radiol"},{"key":"BF03034001_CR15","first-page":"1145","volume":"8","author":"CH Kao","year":"2001","unstructured":"Kao CH, Kwan AS, Kwan JK, Chow MJ. The role of18F-fluorodeoxyglucose positron emission tomography in cancer screening\u2014A preliminary report.Oncology Reports 2001; 8: 1145\u20131148.","journal-title":"Oncology Reports"},{"issue":"12","key":"BF03034001_CR16","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1054\/bjoc.2000.1496","volume":"83","author":"S Yasuda","year":"2000","unstructured":"Yasuda S, Ide M, Fujii H, Nakahara T, Mochizuki Y, Takahashi W, et al. Application of positron emission tomography imaging to cancer screening.Br J Cancer 2000; 83 (12): 1607\u20131611.","journal-title":"Br J Cancer"},{"key":"BF03034001_CR17","first-page":"855","volume":"49","author":"S Jinnouchi","year":"2004","unstructured":"Jinnouchi S. Could FDG-PET change the conventional scheme of cancer screening?Jpn J Clin Radiol 2004; 49: 855\u2013863.","journal-title":"Jpn J Clin Radiol"},{"key":"BF03034001_CR18","first-page":"441","volume":"37","author":"H Engel","year":"1996","unstructured":"Engel H, Steinert H, Buck A, Berthold T, Huch Boni RA, von Schulthess GK. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.J Nucl Med 1996; 37: 441\u2013446.","journal-title":"J Nucl Med"},{"key":"BF03034001_CR19","volume-title":"TNM Classification of Malignant Tumors","year":"1997","unstructured":"Sobin LH, Wittekind CH, eds.TNM Classification of Malignant Tumors, 5th ed. New York; John Wiley & Sons, Inc., 1997.","edition":"5th ed."},{"key":"BF03034001_CR20","volume-title":"The Statistics of Cancer Screening 2003","author":"Japan Cancer Society","year":"2003","unstructured":"Japan Cancer Society.The Statistics of Cancer Screening 2003. Tokyo; Japan Cancer Society, 2003."},{"key":"BF03034001_CR21","volume-title":"Annual report of gastroenterological mass survey in Japan 2002","author":"Japanese Society of Gastroenterological Mass Survey","year":"2002","unstructured":"Japanese Society of Gastroenterological Mass Survey.Annual report of gastroenterological mass survey in Japan 2002. Tokyo; Japanese Society of Gastroenterological Mass Survey, 2002."},{"key":"BF03034001_CR22","first-page":"841","volume":"49","author":"K Uno","year":"2004","unstructured":"Uno K, Woo J, Suzuki T, Suzuki H, Kosaka N, Matsuo Y, et al. What are the problems of cancer screening using FDG-PET?Jpn J Clin Radiol 2004; 49: 841\u2013846.","journal-title":"Jpn J Clin Radiol"},{"key":"BF03034001_CR23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s005950170044","volume":"31","author":"WY Chung","year":"2001","unstructured":"Chung WY, Chang HS, Kim EK, Park CS. Ultrasonographic mass screening for thyroid carcinoma: a study in women scheduled to undergo a breast examination.Surgery Today 2001; 31: 763\u2013767.","journal-title":"Surgery Today"},{"key":"BF03034001_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000085586","volume":"26","author":"P Siironen","year":"2005","unstructured":"Siironen P, Louhimo J, Nordling S, Ristim\u00e4ki A, M\u00e4enp\u00e4\u00e4 H, Haapiainen R, et al. Prognostic Factors in Papillary Thyroid Cancer: An Evaluation of 601 Consecutive Patients.Tumor Biology 2005; 26: 57\u201364.","journal-title":"Tumor Biology"},{"issue":"4","key":"BF03034001_CR25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2002.20.4.911","volume":"20","author":"T Sobue","year":"2002","unstructured":"Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project.J Clin Oncol 2002; 20 (4): 911\u2013920.","journal-title":"J Clin Oncol"},{"issue":"1","key":"BF03034001_CR26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2004.01.009","volume":"45","author":"H Nomori","year":"2004","unstructured":"Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.Lung Cancer 2004; 45 (1): 19\u201327.","journal-title":"Lung Cancer"},{"issue":"2","key":"BF03034001_CR27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00259-002-1029-5","volume":"30","author":"A Stahl","year":"2003","unstructured":"Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings.Eur J Nucl Med 2003; 30 (2): 288\u2013295.","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"BF03034001_CR28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000049823","volume":"40","author":"C Hofer","year":"2001","unstructured":"Hofer C, Kubler H, Hartung R, Breul J, Avril N. Diagnosis and monitoring of urological tumors using positron emission tomography.Eur Urol 2001; 40 (5): 481\u2013487.","journal-title":"Eur Urol"},{"issue":"3","key":"BF03034001_CR29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1040-8428(02)00002-1","volume":"43","author":"T Merminod","year":"2002","unstructured":"Merminod T, Zulian GB. Multiple malignant tumours in the elderly.Crit Rev Oncol Hematol 2002; 43 (3): 227\u2013230.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF03034001_CR30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00006231-200503000-00008","volume":"26","author":"Y Nishiyama","year":"2005","unstructured":"Nishiyama Y, Yamamoto Y, Yokoe K, Miyabe K, Ogawa T, Toyama Y, et al. FDG PET as a procedure for detecting simultaneous tumours in head and neck cancer patients.Nucl Med Commun 2005; 26: 239\u2013244.","journal-title":"Nucl Med Commun"},{"key":"BF03034001_CR31","first-page":"752","volume":"46","author":"T Ishimori","year":"2005","unstructured":"Ishimori T, Patel PV, Wahl RL. Detection of Unexpected Additional Primary Malignancies with PET\/CT.J Nucl Med 2005; 46: 752\u2013757.","journal-title":"J Nucl Med"},{"key":"BF03034001_CR32","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archotol.126.12.1457","volume":"126","author":"E Martino Di","year":"2000","unstructured":"Di Martino E, Nowak B, Hassan HA, Hausmann R, Adam G, Buell U, et al. Diagnosis and staging of head and neck cancer.Arch Otolaryngol Head Neck Surg 2000; 126: 1457\u20131461.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"BF03034001_CR33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0720-048X(98)00139-9","volume":"30","author":"G Robert","year":"1999","unstructured":"Robert G, Milne R. A Selphi study to establish national cost-effectiveness research priorities for positron emission tomography.Eur J Radiol 1999; 30: 54\u201360.","journal-title":"Eur J Radiol"},{"key":"BF03034001_CR34","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF03178045","volume":"26","author":"A Vade","year":"1996","unstructured":"Vade A, Demos TC, Olson MC, Subbaiah P, Turbin RC, Vickery K, et al. Evaluation of image quality using 1\u22361 pitch and 1.5\u22361 pitch helical CT in children: a comparative study.Pediatr Radiol 1996; 26: 891\u2013893.","journal-title":"Pediatr Radiol"},{"issue":"3","key":"BF03034001_CR35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02984601","volume":"19","author":"S Yasuda","year":"2005","unstructured":"Yasuda S, Ide M. PET and cancer screening.Ann Nucl Med 2005; 19 (3): 167\u2013177.","journal-title":"Ann Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03034001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03034001\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03034001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:44:54Z","timestamp":1558572294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03034001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["BF03034001"],"URL":"https:\/\/doi.org\/10.1007\/bf03034001","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}